Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem, 41418-41419 [2023-13473]
Download as PDF
<![CDATA[
41418
Federal Register / Vol. 88, No. 121 / Monday, June 26, 2023 / Notices
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register on November 18, 2022
(87 FR 69338). The Commission
conducted its hearing on April 11, 2023.
All persons who requested the
opportunity were permitted to
participate.
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determinations
in these reviews on June 20, 2023. The
views of the Commission are contained
in USITC Publication 5432 (June 2023),
entitled Frozen Warmwater Shrimp
from China, India, Thailand, and
Vietnam: Investigation Nos. 731–TA–
1064 and 1066–1068 (Third Review).
By order of the Commission.
Issued: June 20, 2023.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2023–13444 Filed 6–23–23; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 7020–02–P
Drug Enforcement Administration
[Docket No. DEA–1221]
Bulk Manufacturer of Controlled
Substances Application: American
Radiolabeled Chem
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
American Radiolabeled Chem
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 25, 2023. Such
persons may also file a written request
for a hearing on the application on or
before August 25, 2023.
SUMMARY:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
ADDRESSES:
DEPARTMENT OF JUSTICE
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 19, 2023,
American Radiolabeled Chem, 100 Arc
Drive, St. Louis, Missouri 63146–3502,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug
code
Schedule
Gamma Hydroxybutyric Acid ..........................................................................................................................................................
Ibogaine ..........................................................................................................................................................................................
Lysergic acid diethylamide .............................................................................................................................................................
Tetrahydrocannabinols ...................................................................................................................................................................
Dimethyltryptamine .........................................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ..............................................................................................................................................
Noroxymorphone ............................................................................................................................................................................
Heroin .............................................................................................................................................................................................
Normorphine ...................................................................................................................................................................................
Amphetamine .................................................................................................................................................................................
Methamphetamine ..........................................................................................................................................................................
Amobarbital ....................................................................................................................................................................................
Phencyclidine .................................................................................................................................................................................
Phenylacetone ................................................................................................................................................................................
Cocaine ..........................................................................................................................................................................................
Codeine ..........................................................................................................................................................................................
Dihydrocodeine ...............................................................................................................................................................................
Oxycodone .....................................................................................................................................................................................
Hydromorphone ..............................................................................................................................................................................
Ecgonine .........................................................................................................................................................................................
Hydrocodone ..................................................................................................................................................................................
Meperidine ......................................................................................................................................................................................
Metazocine .....................................................................................................................................................................................
Methadone ......................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................................
Morphine .........................................................................................................................................................................................
Oripavine ........................................................................................................................................................................................
Thebaine .........................................................................................................................................................................................
Oxymorphone .................................................................................................................................................................................
Phenazocine ...................................................................................................................................................................................
Carfentanil ......................................................................................................................................................................................
Fentanyl ..........................................................................................................................................................................................
2010
7260
7315
7370
7435
7470
9145
9200
9313
1100
1105
2125
7471
8501
9041
90.50
9120
9143
9150
9180
9193
9230
9240
9250
9273
9300
9330
9333
9652
9715
9743
9801
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
VerDate Sep<11>2014
19:33 Jun 23, 2023
Jkt 259001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
E:\FR\FM\26JNN1.SGM
26JNN1
41419
Federal Register / Vol. 88, No. 121 / Monday, June 26, 2023 / Notices
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. The company plans to
manufacture small quantities of the
above-listed controlled substances as
radiolabeled compounds for
biochemical research. No other
activities for these drug codes are
authorized for this registration.
ACTION:
Notice of application.
Arista Biologicals has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 25, 2023. Such
persons may also file a written request
for a hearing on the application on or
before August 25, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
SUMMARY:
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–13473 Filed 6–23–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1203]
Bulk Manufacturer of Controlled
Substances Application: Arista
Biologicals
Drug Enforcement
Administration, Justice.
AGENCY:
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on April 6, 2023, Arista
Biologicals, 1101 Hamilton Street,
Allentown, Pennsylvania 18101–1043,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
4-Anilino-N-Phenethyl-4-Piperidine (ANPP) ...........................................................................................................................
Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) ..........................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for internal use as
intermediates for formulation and
analytical development purposes. No
other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–13466 Filed 6–23–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1220]
Bulk Manufacturer of Controlled
Substances Application: Olon Ricerca
Bioscience LLC
Drug Enforcement
Administration, Justice.
ddrumheller on DSK120RN23PROD with NOTICES1
AGENCY:
ACTION:
Notice of application.
Olon Ricerca Bioscience LLC,
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 25, 2023. Such
persons may also file a written request
for a hearing on the application on or
before August 25, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 17, 2023, Olon
Ricerca Bioscience LLC, 7528 Auburn
Road, Concord Township, Ohio 44077–
9176 applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Amphetamine .................................................................................................................................................................................
Lisdexamfetamine ..........................................................................................................................................................................
19:33 Jun 23, 2023
Jkt 259001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
II
II
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
Controlled substance
VerDate Sep<11>2014
8333
8366
Schedule
E:\FR\FM\26JNN1.SGM
26JNN1
Drug
code
Schedule
1100
1205
II
II
]]>Agencies
[Federal Register Volume 88, Number 121 (Monday, June 26, 2023)]
[Notices]
[Pages 41418-41419]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13473]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1221]
Bulk Manufacturer of Controlled Substances Application: American
Radiolabeled Chem
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: American Radiolabeled Chem has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
August 25, 2023. Such persons may also file a written request for a
hearing on the application on or before August 25, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 19, 2023, American Radiolabeled Chem, 100 Arc
Drive, St. Louis, Missouri 63146-3502, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............... 2010 I
Ibogaine................................ 7260 I
Lysergic acid diethylamide.............. 7315 I
Tetrahydrocannabinols................... 7370 I
Dimethyltryptamine...................... 7435 I
1-[1-(2-Thienyl)cyclohexyl]piperidine... 7470 I
Noroxymorphone.......................... 9145 I
Heroin.................................. 9200 I
Normorphine............................. 9313 I
Amphetamine............................. 1100 II
Methamphetamine......................... 1105 II
Amobarbital............................. 2125 II
Phencyclidine........................... 7471 II
Phenylacetone........................... 8501 II
Cocaine................................. 9041 II
Codeine................................. 90.50 II
Dihydrocodeine.......................... 9120 II
Oxycodone............................... 9143 II
Hydromorphone........................... 9150 II
Ecgonine................................ 9180 II
Hydrocodone............................. 9193 II
Meperidine.............................. 9230 II
Metazocine.............................. 9240 II
Methadone............................... 9250 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine................................ 9300 II
Oripavine............................... 9330 II
Thebaine................................ 9333 II
Oxymorphone............................. 9652 II
Phenazocine............................. 9715 II
Carfentanil............................. 9743 II
Fentanyl................................ 9801 II
------------------------------------------------------------------------
[[Page 41419]]
The company plans to bulk manufacture the listed controlled
substances for the internal use intermediates or for sale to its
customers. The company plans to manufacture small quantities of the
above-listed controlled substances as radiolabeled compounds for
biochemical research. No other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-13473 Filed 6-23-23; 8:45 am]
BILLING CODE P
